In this article, comparative data is presented proving that trabeculectomy is more effective than non-penetrating options, however, does pose an increased risk of complications, leading to the conclusion that at the moment, procedures should be chosen on an individual basis.
First-person perspective: Prof Shlomo Melamed on lessons from the Togo Glaucoma Project
March 30th 2023On a recent trip to Togo, West Africa, my colleagues and I taught local ophthalmologists to perform selective laser trabeculoplasty in a model that we hope to see replicated throughout the region.
Glaucoma 360: Eyedrop targets and reduces episcleral venous pressure in glaucoma
February 8th 2023Thurein Htoo, MS, MBA, CEO and co-founder of Qlaris Bio, took the podium at the New Horizons Forum at the Glaucoma 360 conference in San Francisco to discuss the performance of the company’s episcleral venous pressure eyedrop, QLS-111.
2 Clarke Drive
Cranbury, NJ 08512